$IPSC insider trading
Over the last 12 months, Century Therapeutics insiders reported 3 buys totaling $97K and 20 sales totaling $86K across SEC Form 4 filings.
- Bought · 12m
- $97K 3 events
- Sold · 12m
- $86K 20 events
- Events · 12m
- 23 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Russotti GregorySee Remarks · O | ▼ Sale | 2,587 | $1.93 | $5K | -0.5% | — |
| Sep 14, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 1,658 | $1.93 | $3K | -0.3% | — |
| Sep 8, 2026 | Russotti GregorySee Remarks · O | ▼ Sale | 534 | $2.05 | $1K | -0.1% | — |
| Sep 8, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 254 | $2.05 | $521 | -0.1% | — |
| Aug 3, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 275 | $1.98 | $544 | -0.1% | — |
| Jun 12, 2026 | Russotti GregorySee Remarks · O | ▼ Sale | 2,584 | $2.23 | $6K | -0.5% | — |
| Jun 12, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 1,654 | $2.23 | $4K | -0.3% | — |
| Jun 8, 2026 | Russotti GregorySee Remarks · O | ▼ Sale | 524 | $2.11 | $1K | -0.1% | — |
| Jun 8, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 249 | $2.11 | $526 | — | — |
| May 4, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 264 | $2.34 | $618 | -0.1% | — |
| Mar 12, 2026 | Russotti GregorySee Remarks · O | ▼ Sale | 10,076 | $2.55 | $26K | -1.9% | — |
| Mar 12, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 7,043 | $2.55 | $18K | -1.4% | — |
| Mar 9, 2026 | Russotti GregorySee Remarks · O | ▼ Sale | 479 | $2.54 | $1K | -0.1% | — |
| Mar 9, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 247 | $2.54 | $626 | — | — |
| Feb 3, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 323 | $1.82 | $589 | -0.1% | — |
| Dec 22, 2025 | Cowan ChadChief Scientific Officer · O | ▲ Buy | 58,060 | $0.85 | $49K | +5.9% | late |
| Dec 12, 2025 | Pfeiffenberger BrentPresident and CEO · O·D | ▲ Buy | 52,000 | $0.58 | $30K | +1.6% | — |
| Dec 8, 2025 | Russotti GregorySee Remarks · O | ▼ Sale | 526 | $0.53 | $280 | -0.1% | — |
| Dec 8, 2025 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 257 | $0.53 | $137 | -0.1% | — |
| Nov 20, 2025 | Cowan ChadChief Scientific Officer · O | ▼ Sale | 5,462 | $0.5 | $3K | -0.6% | — |
| Nov 19, 2025 | Pfeiffenberger BrentPresident and CEO · O·D | ▲ Buy | 35,000 | $0.5 | $17K | +1.1% | — |
| Nov 17, 2025 | Pfeiffenberger BrentPresident and CEO · O·D | ▼ Sale | 32,456 | $0.45 | $15K | -1% | — |
| Nov 3, 2025 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 292 | $0.59 | $171 | -0.1% | — |
| Sep 8, 2025 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 263 | $0.5 | $132 | -0.1% | — |
| Sep 8, 2025 | Pfeiffenberger BrentPresident and CEO · O·D | ▼ Sale | 488 | $0.5 | $244 | — | — |
| Sep 8, 2025 | Russotti GregorySee Remarks · O | ▼ Sale | 539 | $0.5 | $270 | -0.1% | — |
Every $IPSC filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Century Therapeutics filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $IPSC feed.